Statistical Decision Properties of Imprecise Trials Assessing COVID-19 Drugs

Charles F. Manski, Aleksey Tetenov
doi: https://doi.org/10.1101/2020.05.26.20114009

Article usage

Article usage: June 2020 to December 2024

AbstractFullPdf
Jun 20208050177
Jul 2020122050
Aug 20201110141
Sep 2020115038
Oct 202031016
Nov 202040015
Dec 20202003
Jan 202134117
Feb 20214719
Mar 202166212
Apr 20215134
May 202165413
Jun 20215725
Jul 202134319
Aug 20213395
Sep 202128010
Oct 20213227
Nov 20213128
Dec 20211642
Jan 20221752
Feb 20222804
Mar 20221805
Apr 20221713
May 202222010
Jun 20221204
Jul 20221503
Aug 20222444
Sep 20222507
Oct 20222619
Nov 20221803
Dec 20221234
Jan 20231802
Feb 20231527
Mar 2023600
Apr 20232516
May 202314211
Jun 20231244
Jul 20231004
Aug 202324136
Sep 20231653
Oct 20231105
Nov 2023903
Dec 2023712
Jan 20241002
Feb 2024816
Mar 20241235
Apr 2024845
May 2024301
Jun 20241025
Jul 2024636
Aug 2024506
Sep 202424116
Oct 20249611
Nov 202416512
Dec 2024516
Back to top
Posted June 15, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Statistical Decision Properties of Imprecise Trials Assessing COVID-19 Drugs
Charles F. Manski, Aleksey Tetenov
medRxiv 2020.05.26.20114009; doi: https://doi.org/10.1101/2020.05.26.20114009
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area